speb/financial-data huggingface dataset:
Financial ratios for BCC — quarterly report dated 2025-06-30
Total revenue: 1740114000
Gross profit: 298655000
Operating income: 80530000
Net income: 61985000
Capital expenditures: 79052000
Operating cash flow: 33170000
Depreciation & amortization: 38381000
Net tangible assets: 1817256000
Owner earnings: 21314000
Return on net tangible assets (%): 1.1728672239904558
Capex to operating income (%): 98.16465913324227
Buffett classification: The Gruesome
Stock price: 86.12
P/E ratio: 29.614494486822434
Shares outstanding: 35189736
Book value: 2152057000
P/B ratio: 1.4082062251696865
Market cap (USD): 3030540064.32
Debt to equity: 0.23601187143277338
Current ratio: 2.9620157225490864
Quick ratio: 1.5376913395785414
Effective tax rate (%): 23.091716710506724
Interest coverage ratio: 15.537333590584604
COGS to revenue (%): 82.83704400976029
SG&A to revenue (%): 10.820268097377529
Free cash flow (dilution-adjusted): -49135000
Buyback yield (%): 1.1173585988409638
Retained earnings: 2014674000
Inventory turnover: 1.5685815549585018
Receivables turnover: 3.6203123667177777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8757396914570212
FCF margin (%): -2.8236655759335307
Revenue growth (%): 13.252248300351319
Rule of 40 score: 10.428582724417788
Financial ratios for BCC — quarterly report dated 2025-09-30
Total revenue: 1667806000
Gross profit: 263495000
Operating income: 32329000
Net income: 21769000
Capital expenditures: 55190000
Operating cash flow: 118438000
Depreciation & amortization: 43293000
Net tangible assets: 1813669000
Owner earnings: 9872000
Return on net tangible assets (%): 0.5443110071352601
Capex to operating income (%): 170.7136007918587
Buffett classification: The Gruesome
Stock price: 76.89
P/E ratio: 21.802539854635704
Shares outstanding: 35189736
Book value: 2143385000
P/B ratio: 1.2623671440455169
Market cap (USD): 2705738801.04
Debt to equity: 0.2390802399009044
Current ratio: 3.0979070906771313
Quick ratio: 1.68609537058557
Effective tax rate (%): 29.451988203649094
Interest coverage ratio: 6.068894311995495
COGS to revenue (%): 84.20110012795253
SG&A to revenue (%): 11.442397976743099
Free cash flow (dilution-adjusted): 60190000
Buyback yield (%): 0.9223358880911825
Retained earnings: 1574287000
Inventory turnover: 1.6631701245206416
Receivables turnover: 3.6025618317312884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1529830838276371
FCF margin (%): 3.6089329334466957
Revenue growth (%): -4.155359936188089
Rule of 40 score: -0.5464270027413929
Financial ratios for BCC — annual report dated 2025-12-31
Total revenue: 6404595000
Gross profit: 1053893000
Operating income: 183329000
Net income: 132836000
Capital expenditures: 241431000
Operating cash flow: 254148000
Depreciation & amortization: 161849000
Net tangible assets: 1729829000
Owner earnings: 53254000
Return on net tangible assets (%): 3.078570193932464
Capex to operating income (%): 131.6927491013424
Buffett classification: The Gruesome
Stock price: 73.4
P/E ratio: 19.444477569333614
Shares outstanding: 35189736
Book value: 2074878000
P/B ratio: 1.2448571060081606
Market cap (USD): 2582926622.4
Debt to equity: 0.24618989646620187
Current ratio: 3.3553001971298544
Quick ratio: 1.7415043522702383
Effective tax rate (%): 26.18294776969542
Interest coverage ratio: 8.391879520278312
COGS to revenue (%): 83.54473624015257
SG&A to revenue (%): 11.178724025484827
Free cash flow (dilution-adjusted): 598000
Buyback yield (%): 7.0891677065862595
Retained earnings: 1503772000
Inventory turnover: 6.72431898497469
Receivables turnover: 18.79679685849123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.669256824720876
FCF margin (%): 0.00933704629254465
Revenue growth (%): -4.7543875981627215
Rule of 40 score: -4.745050551870177
Financial ratios for BCC — quarterly report dated 2025-12-31
Total revenue: 1460181000
Gross profit: 231432000
Operating income: 15951000
Net income: 8734000
Capital expenditures: 53984000
Operating cash flow: 131016000
Depreciation & amortization: 42215000
Net tangible assets: 1729829000
Owner earnings: -3035000
Return on net tangible assets (%): -0.1754508682650135
Capex to operating income (%): 338.43646166384553
Buffett classification: The Gruesome
Stock price: 73.4
P/E ratio: 19.444477569333614
Shares outstanding: 35189736
Book value: 2074878000
P/B ratio: 1.2448571060081606
Market cap (USD): 2582926622.4
Debt to equity: 0.24618989646620187
Current ratio: 3.3553001971298544
Quick ratio: 1.7415043522702383
Effective tax rate (%): 38.94869285614428
Interest coverage ratio: 2.6479083665338647
COGS to revenue (%): 84.15045805965151
SG&A to revenue (%): 11.518092620024504
Free cash flow (dilution-adjusted): 74981000
Buyback yield (%): 2.7258226923450213
Retained earnings: 1503772000
Inventory turnover: 1.5441899452574008
Receivables turnover: 4.285474043812073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5802754371164556
FCF margin (%): 5.135048326200656
Revenue growth (%): -12.44898987052451
Rule of 40 score: -7.313941544323854
Financial ratios for CLFD — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.15
Shares outstanding: 13589460
Market cap (USD): 599974659
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLFD — annual report dated 2022-09-30
Total revenue: 270883000
Gross profit: 112947000
Operating income: 63817000
Net income: 49362000
Capital expenditures: 9148000
Operating cash flow: 2258000
Depreciation & amortization: 3426000
Net tangible assets: 134803000
Owner earnings: 43640000
Return on net tangible assets (%): 32.37316676928555
Capex to operating income (%): 14.334738392591314
Buffett classification: The Great
Stock price: 104.64
P/E ratio: 28.807606952716664
Shares outstanding: 13589460
Book value: 147582000
P/B ratio: 9.635328796194658
Market cap (USD): 1422001094.4
Debt to equity: 0.2199658494938407
Current ratio: 3.09749680814021
Quick ratio: 1.507215537586567
Effective tax rate (%): 22.671303693956197
Interest coverage ratio: 205.19935691318327
COGS to revenue (%): 58.304138687182295
SG&A to revenue (%): 18.13698164890377
Free cash flow (dilution-adjusted): -9229000
Buyback yield (%): 0.09887474809527122
Retained earnings: 94803000
Inventory turnover: 1.9211755546905411
Receivables turnover: 5.044000446894086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.96661293776841
FCF margin (%): -3.4070059767501095
Rule of 40 score: -3.4070059767501095
Financial ratios for CLFD — annual report dated 2023-09-30
Total revenue: 225722000
Gross profit: 79857000
Operating income: 37577000
Net income: 32533000
Capital expenditures: 7439000
Operating cash flow: 24596000
Depreciation & amortization: 4915000
Net tangible assets: 302543000
Owner earnings: 30009000
Return on net tangible assets (%): 9.91892061624298
Capex to operating income (%): 19.79668414189531
Buffett classification: The Great
Stock price: 28.66
P/E ratio: 11.971657197307348
Shares outstanding: 13589460
Book value: 315163000
P/B ratio: 1.2357856842332382
Market cap (USD): 389473923.6
Debt to equity: 0.05228405618679858
Current ratio: 10.21428078885671
Quick ratio: 6.833540201351537
Effective tax rate (%): 20.849176172370086
Interest coverage ratio: 221.04117647058823
COGS to revenue (%): 64.62152559342908
SG&A to revenue (%): 18.731005396018112
Free cash flow (dilution-adjusted): 13579000
Buyback yield (%): 0.3132430507088254
Retained earnings: 127336000
Inventory turnover: 1.4875834990566519
Receivables turnover: 7.950197238658777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.508576993871607
FCF margin (%): 6.015807054695599
Revenue growth (%): -16.67177342247391
Rule of 40 score: -10.655966367778309
Financial ratios for CLFD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.96
Shares outstanding: 13589460
Market cap (USD): 529445361.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLFD — annual report dated 2024-09-30
Total revenue: 125568000
Gross profit: 25847000
Operating income: -19234000
Net income: -12453000
Capital expenditures: 7940000
Operating cash flow: 17770000
Depreciation & amortization: 5924000
Net tangible assets: 266383000
Owner earnings: -14469000
Return on net tangible assets (%): -5.431652920794495
Buffett classification: The Gruesome
Stock price: 38.96
Shares outstanding: 13589460
Book value: 275763000
P/B ratio: 1.9199289302770857
Market cap (USD): 529445361.6
Debt to equity: 0.04093732661742148
Current ratio: 9.428178383705651
Quick ratio: 7.124630420499343
COGS to revenue (%): 79.41593399592253
SG&A to revenue (%): 35.9016628440367
Free cash flow (dilution-adjusted): 5410000
Buyback yield (%): 6.396694060677553
Retained earnings: 114962000
Inventory turnover: 1.7776846833998858
Receivables turnover: 9.070866141732283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.611371393805234
FCF margin (%): 4.30842252803262
Revenue growth (%): -44.37050885602644
Rule of 40 score: -40.06208632799382
Financial ratios for CLFD — quarterly report dated 2024-12-31
Capital expenditures: 1751000
Buffett classification: The Gruesome
Stock price: 31
Shares outstanding: 13589460
Market cap (USD): 421273260
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLFD — quarterly report dated 2025-03-31
Total revenue: 40621000
Gross profit: 13961000
Operating income: 1682000
Net income: 1327000
Capital expenditures: 1323000
Operating cash flow: 4411000
Depreciation & amortization: 1548000
Net tangible assets: 253458000
Owner earnings: 1552000
Return on net tangible assets (%): 0.6123302480095322
Capex to operating income (%): 78.6563614744352
Buffett classification: The Gruesome
Stock price: 29.72
P/E ratio: 76.0886871137905
Shares outstanding: 13589460
Book value: 265899000
P/B ratio: 1.5189179019101238
Market cap (USD): 403878751.2
Debt to equity: 0.08139932831639081
Current ratio: 6.7637722980062955
Quick ratio: 4.924711437565582
Effective tax rate (%): 22.079510703363916
Interest coverage ratio: 24.3768115942029
COGS to revenue (%): 65.63107752147904
SG&A to revenue (%): 30.228207085005295
Free cash flow (dilution-adjusted): 1917000
Buyback yield (%): 1.174362351549234
Retained earnings: 114384000
Inventory turnover: 0.47535839098495114
Receivables turnover: 1.6788312117705406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5999407906235176
FCF margin (%): 4.719233893798775
Rule of 40 score: 4.719233893798775
Financial ratios for CLFD — quarterly report dated 2025-06-30
Total revenue: 49903000
Gross profit: 15234000
Operating income: 1496000
Net income: 1606000
Capital expenditures: 2147000
Operating cash flow: 5666000
Depreciation & amortization: 2705000
Net tangible assets: 247070000
Owner earnings: 2164000
Return on net tangible assets (%): 0.8758651394341685
Capex to operating income (%): 143.51604278074865
Buffett classification: The Gruesome
Stock price: 43.41
P/E ratio: 201.1314212751449
Shares outstanding: 13589460
Book value: 264476000
P/B ratio: 2.2305179244997655
Market cap (USD): 589918458.5999999
Debt to equity: 0.08195072520758027
Current ratio: 5.92504458314757
Quick ratio: 4.42724587605885
Effective tax rate (%): 46.0711887172599
Interest coverage ratio: 14.11320754716981
COGS to revenue (%): 69.47277718774423
SG&A to revenue (%): 27.529407049676376
Free cash flow (dilution-adjusted): 1995000
Buyback yield (%): 0.9577594865243976
Retained earnings: 115990000
Inventory turnover: 0.6449686529123956
Receivables turnover: 1.87506575486586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5365430274512054
FCF margin (%): 3.9977556459531494
Revenue growth (%): 22.850249870756507
Rule of 40 score: 26.848005516709655
Financial ratios for CLFD — annual report dated 2025-09-30
Total revenue: 150134000
Gross profit: 50537000
Operating income: 2118000
Net income: -8050000
Capital expenditures: 3840000
Operating cash flow: 26553000
Depreciation & amortization: 6121000
Net tangible assets: 242101000
Owner earnings: -5769000
Return on net tangible assets (%): -2.382889785667965
Capex to operating income (%): 181.3031161473088
Buffett classification: The Gruesome
Stock price: 34.38
Shares outstanding: 13589460
Book value: 256163000
P/B ratio: 1.8238607246167482
Market cap (USD): 467205634.8
Debt to equity: 0.03418526485089572
Current ratio: 5.4227249132584765
Quick ratio: 4.2744310575635875
Effective tax rate (%): 27.195107880466136
COGS to revenue (%): 66.33873739459416
SG&A to revenue (%): 32.25052286623949
Free cash flow (dilution-adjusted): 17213000
Buyback yield (%): 3.670118406714045
Retained earnings: 106912000
Inventory turnover: 2.3696081463681566
Receivables turnover: 8.34495025290423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7856957376562674
FCF margin (%): 11.46509118520788
Revenue growth (%): 19.563901630988788
Rule of 40 score: 31.02899281619667
Financial ratios for CLFD — quarterly report dated 2025-09-30
Total revenue: 17587000
Gross profit: 12930000
Operating income: 4334000
Net income: -9078000
Capital expenditures: 1381000
Operating cash flow: 8437000
Depreciation & amortization: 355000
Net tangible assets: 242101000
Owner earnings: -10104000
Return on net tangible assets (%): -4.173464793619193
Capex to operating income (%): 31.864328564836182
Buffett classification: The Good
Stock price: 34.38
Shares outstanding: 13589460
Book value: 256163000
P/B ratio: 1.8238607246167482
Market cap (USD): 467205634.8
Debt to equity: 0.03418526485089572
Current ratio: 5.4227249132584765
Quick ratio: 4.2744310575635875
Effective tax rate (%): 15.325424815646041
COGS to revenue (%): 26.479786205720135
SG&A to revenue (%): 48.877011428896346
Free cash flow (dilution-adjusted): 8063000
Buyback yield (%): 0.002568462173008021
Retained earnings: 106912000
Inventory turnover: 0.11079917203968499
Receivables turnover: 0.9775443277194152
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6077456690284528
FCF margin (%): 45.84636379143686
Revenue growth (%): -64.75762980181553
Rule of 40 score: -18.911266010378668
Financial ratios for CLFD — quarterly report dated 2025-12-31
Total revenue: 34341000
Gross profit: 11388000
Operating income: -1824000
Net income: -614000
Capital expenditures: 988000
Operating cash flow: -1440000
Depreciation & amortization: 1615000
Net tangible assets: 236014000
Owner earnings: 13000
Buffett classification: The Gruesome
Stock price: 29.15
Shares outstanding: 13589460
Book value: 249652000
P/B ratio: 1.5867397777706567
Market cap (USD): 396132759
Debt to equity: 0.03236104657683495
Current ratio: 12.547429782723901
Quick ratio: 9.503974562798092
COGS to revenue (%): 66.83847296234822
SG&A to revenue (%): 38.47296234821351
Free cash flow (dilution-adjusted): -3699000
Buyback yield (%): 1.5843173424594255
Retained earnings: 106298000
Inventory turnover: 0.5709559463694933
Receivables turnover: 2.2938347471778773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7157404028394175
FCF margin (%): -10.771381147899014
Revenue growth (%): 95.26354693807926
Rule of 40 score: 84.49216579018025
Financial ratios for CMSINFO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.289858894896479
Shares outstanding: 160063415
Market cap (USD): 526586049.58525646
Buyback yield (%): 0
Retained earnings: 129007912.43571146
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMSINFO.NS — annual report dated 2023-03-31
Total revenue: 233219244.82338613
Gross profit: 213551278.92813644
Operating income: 62291717.41778319
Net income: 36204141.29110841
Capital expenditures: 23308282.58221681
Operating cash flow: 49544823.3861145
Depreciation & amortization: 16055785.627283802
Net tangible assets: 163878075.5176614
Owner earnings: 28951644.3361754
Return on net tangible assets (%): 17.6665757421927
Capex to operating income (%): 37.41794824164329
Buffett classification: The Good
Stock price: 3.188063337393423
P/E ratio: 14.094860058034694
Shares outstanding: 160063415
Book value: 190311205.84652862
P/B ratio: 2.681357110579185
Market cap (USD): 510292305.0194885
Debt to equity: 0.13013878799709433
Current ratio: 2.9601748288225957
Quick ratio: 2.7565464718511317
Effective tax rate (%): 25.87945149457504
Interest coverage ratio: 26.072648483303595
COGS to revenue (%): 8.43325168561625
SG&A to revenue (%): 4.894528210243742
Free cash flow (dilution-adjusted): 24867844.092570037
Buyback yield (%): 0
Retained earnings: 153418514.0073082
Inventory turnover: 2.1770796818120535
Receivables turnover: 3.640150341347863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.44270068118071
FCF margin (%): 10.66286108224136
Rule of 40 score: 10.66286108224136
Financial ratios for CMSINFO.NS — annual report dated 2024-03-31
Total revenue: 271576567.933805
Gross profit: 237623935.72370788
Operating income: 65996282.52788104
Net income: 41628612.54347044
Capital expenditures: 12722148.93872167
Operating cash flow: 52751289.12339609
Depreciation & amortization: 18014630.051564936
Net tangible assets: 207571651.27713156
Owner earnings: 46921093.6563137
Return on net tangible assets (%): 22.60476966272661
Capex to operating income (%): 19.277069027860808
Buffett classification: The Great
Stock price: 4.518234165067178
P/E ratio: 17.37276229120355
Shares outstanding: 160063415
Book value: 233452332.4139585
P/B ratio: 3.0978657730775567
Market cap (USD): 723203990.2303263
Debt to equity: 0.09290107301417382
Current ratio: 2.933672969885962
Quick ratio: 2.7036749641931213
Effective tax rate (%): 25.675128838112528
Interest coverage ratio: 33.950832819247374
COGS to revenue (%): 12.502047753388231
SG&A to revenue (%): 4.697181982242943
Free cash flow (dilution-adjusted): 35371387.45652956
Buyback yield (%): 0
Retained earnings: 178907063.197026
Inventory turnover: 2.2318382468863316
Receivables turnover: 3.146639007493264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.12031396983513
FCF margin (%): 13.024462208076473
Revenue growth (%): 16.446894483114527
Rule of 40 score: 29.471356691190998
Financial ratios for CMSINFO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 224892379.35977066
Buffett classification: The Gruesome
Stock price: 6.941591017677974
Shares outstanding: 160063415
Book value: 251088150.97945535
P/B ratio: 4.425118268180541
Market cap (USD): 1111094763.822862
Debt to equity: 0.08861857847591229
Current ratio: 3.040692071908712
Quick ratio: 2.903331819453965
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMSINFO.NS — quarterly report dated 2024-12-31
Total revenue: 67781093.36752535
Gross profit: 64182305.6300268
Operating income: 13804289.544235924
Net income: 10862921.086373702
Capital expenditures: 0
Depreciation & amortization: 4784240.587481058
Owner earnings: 15647161.67385476
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.553910712204219
P/E ratio: 20.458997817714316
Shares outstanding: 160063415
Market cap (USD): 888977915.2004895
Effective tax rate (%): 25.694671461261848
Interest coverage ratio: 25.10110216193302
COGS to revenue (%): 5.309427096410281
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMSINFO.NS — quarterly report dated 2025-03-31
Total revenue: 72371755.90367079
Gross profit: 65349777.88169277
Operating income: 13954991.816693943
Net income: 11405307.458498947
Capital expenditures: 0
Depreciation & amortization: 4993219.546411036
Net tangible assets: 238934767.36029926
Owner earnings: 16398527.004909983
Return on net tangible assets (%): 6.863181606459971
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.270159878632279
P/E ratio: 18.4905095903677
Shares outstanding: 160063415
Book value: 264965396.3058218
P/B ratio: 3.1836602044299984
Market cap (USD): 843559787.7698681
Debt to equity: 0.08362357347009548
Current ratio: 2.6215166577303752
Quick ratio: 2.5061906763082007
Effective tax rate (%): 24.147287725763693
Interest coverage ratio: 26.160639929870698
COGS to revenue (%): 9.702649789683848
Buyback yield (%): 0
Retained earnings: 205354687.86532614
Inventory turnover: 0.7547591822374126
Receivables turnover: 0.7600076115179454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.912681996531479
Revenue growth (%): 6.772777345525779
Rule of 40 score: 6.772777345525779
Financial ratios for CMSINFO.NS — annual report dated 2025-03-31
Total revenue: 283438391.3958382
Gross profit: 255504793.07926115
Operating income: 54401917.23170446
Net income: 43541851.76525602
Capital expenditures: 17757774.140752863
Operating cash flow: 56409632.92027121
Depreciation & amortization: 18875029.226093054
Net tangible assets: 238934767.36029926
Owner earnings: 44659106.850596204
Return on net tangible assets (%): 18.69092026412923
Capex to operating income (%): 32.64181676745016
Buffett classification: The Good
Stock price: 5.270159878632279
P/E ratio: 19.373539561837884
Shares outstanding: 160063415
Book value: 264965396.3058218
P/B ratio: 3.1836602044299984
Market cap (USD): 843559787.7698681
Debt to equity: 0.08362357347009548
Current ratio: 2.6215166577303752
Quick ratio: 2.5061906763082007
Effective tax rate (%): 25.185250653323664
Interest coverage ratio: 25.57311644776611
COGS to revenue (%): 9.855262788859871
SG&A to revenue (%): 5.125195295421961
Free cash flow (dilution-adjusted): 34772737.90039747
Buyback yield (%): 0
Retained earnings: 205354687.86532614
Inventory turnover: 3.0024502720430246
Receivables turnover: 2.976511101153391
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.15152103788952
FCF margin (%): 12.268182065652256
Revenue growth (%): 4.367763961478611
Rule of 40 score: 16.635946027130867
Financial ratios for CMSINFO.NS — quarterly report dated 2025-06-30
Total revenue: 73415047.97566113
Gross profit: 66841680.31827756
Operating income: 13264919.260472737
Net income: 10950035.10414229
Capital expenditures: 0
Depreciation & amortization: 5209805.757079336
Owner earnings: 16159840.861221626
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.80610812075825
P/E ratio: 27.97694375260812
Shares outstanding: 160063415
Market cap (USD): 929345493.6677978
Effective tax rate (%): 25.491460647318764
Interest coverage ratio: 27.501698204754973
COGS to revenue (%): 8.953706138777981
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.441573524040231
Rule of 40 score: 1.441573524040231
Financial ratios for CMSINFO.NS — quarterly report dated 2025-12-31
Total revenue: 68867327.61501616
Gross profit: 62769522.11206417
Operating income: 9357691.879246965
Net income: 6394452.48969589
Capital expenditures: 0
Depreciation & amortization: 6194385.6522223465
Owner earnings: 12588838.141918236
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.7493594742118748
P/E ratio: 15.150066443398602
Shares outstanding: 160063415
Market cap (USD): 600135281.5049571
Effective tax rate (%): 25.4777483512489
Interest coverage ratio: 18.671704823294068
COGS to revenue (%): 8.854424462409943
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.194534344175116
Rule of 40 score: -6.194534344175116
Financial ratios for COF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 133.84
Shares outstanding: 613500000
Market cap (USD): 82110840000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COF — annual report dated 2022-12-31
Total revenue: 34250000000
Net income: 7360000000
Capital expenditures: 934000000
Operating cash flow: 13809000000
Depreciation & amortization: 3210000000
Net tangible assets: 37805000000
Owner earnings: 9636000000
Return on net tangible assets (%): 25.48869197196138
Buffett classification: The Gruesome
Stock price: 87.54
P/E ratio: 7.296982336956522
Shares outstanding: 613500000
Book value: 52582000000
P/B ratio: 1.02137214255829
Market cap (USD): 53705790000.00001
Debt to equity: 0.9096649043398882
Effective tax rate (%): 20.346320346320347
COGS to revenue (%): 0
SG&A to revenue (%): 36.32700729927008
Free cash flow (dilution-adjusted): 12561000000
Buyback yield (%): 9.21315932602425
Retained earnings: 57184000000
Receivables turnover: 16.27851711026616
Capitalized R&D asset: 0
FCF margin (%): 36.674452554744526
Rule of 40 score: 36.674452554744526
Financial ratios for COF — annual report dated 2023-12-31
Total revenue: 36787000000
Net income: 4887000000
Capital expenditures: 961000000
Operating cash flow: 20575000000
Depreciation & amortization: 3226000000
Net tangible assets: 43024000000
Owner earnings: 7152000000
Return on net tangible assets (%): 16.623280029750838
Buffett classification: The Gruesome
Stock price: 126.34
P/E ratio: 15.860362185389809
Shares outstanding: 613500000
Book value: 58089000000
P/B ratio: 1.3343247430666736
Market cap (USD): 77509590000
Debt to equity: 0.849007557368865
Effective tax rate (%): 19.156327543424318
COGS to revenue (%): 0
SG&A to revenue (%): 36.183978035719136
Free cash flow (dilution-adjusted): 19101000000
Buyback yield (%): 0.9263369861716466
Retained earnings: 60945000000
Receivables turnover: 14.845439870863599
Capitalized R&D asset: 0
FCF margin (%): 51.92323375105337
Revenue growth (%): 7.4072992700729925
Rule of 40 score: 59.33053302112636
Financial ratios for COF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 146.18
Shares outstanding: 613500000
Market cap (USD): 89681430000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COF — annual report dated 2024-12-31
Total revenue: 39112000000
Net income: 4750000000
Capital expenditures: 1204000000
Operating cash flow: 18159000000
Depreciation & amortization: 3237000000
Net tangible assets: 45492000000
Owner earnings: 6783000000
Return on net tangible assets (%): 14.91031390134529
Buffett classification: The Gruesome
Stock price: 174.65
P/E ratio: 22.557426315789474
Shares outstanding: 613500000
Book value: 60784000000
P/B ratio: 1.762762815872598
Market cap (USD): 107147775000
Debt to equity: 0.7401454330086865
Effective tax rate (%): 19.678510998307953
COGS to revenue (%): 0
SG&A to revenue (%): 35.69237062794027
Free cash flow (dilution-adjusted): 16386000000
Buyback yield (%): 0.6850352235499058
Retained earnings: 64505000000
Receivables turnover: 15.447077409162718
Capitalized R&D asset: 0
FCF margin (%): 41.89507056657803
Revenue growth (%): 6.320167450458042
Rule of 40 score: 48.21523801703607
Financial ratios for COF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 174.65
Shares outstanding: 613500000
Market cap (USD): 107147775000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COF — quarterly report dated 2025-03-31
Total revenue: 10000000000
Net income: 1404000000
Capital expenditures: 348000000
Operating cash flow: 4667000000
Depreciation & amortization: 812000000
Net tangible assets: 48472000000
Owner earnings: 1868000000
Return on net tangible assets (%): 3.853771249381086
Buffett classification: The Gruesome
Stock price: 176.14
P/E ratio: 19.24178952991453
Shares outstanding: 613500000
Book value: 63542000000
P/B ratio: 1.7006372163293568
Market cap (USD): 108061889999.99998
Debt to equity: 0.6483900412325706
Effective tax rate (%): 18.796992481203006
COGS to revenue (%): 0
SG&A to revenue (%): 37.480000000000004
Free cash flow (dilution-adjusted): 4142000000
Buyback yield (%): 0.34702335855869265
Retained earnings: 65616000000
Receivables turnover: 3.8476337052712584
Capitalized R&D asset: 0
FCF margin (%): 41.42
Rule of 40 score: 41.42
Financial ratios for COF — quarterly report dated 2025-06-30
Total revenue: 12577000000
Net income: -4277000000
Capital expenditures: 399000000
Operating cash flow: 6066000000
Depreciation & amortization: 1011000000
Net tangible assets: 64464000000
Owner earnings: -3665000000
Return on net tangible assets (%): -5.685343757756267
Buffett classification: The Gruesome
Stock price: 209.67
Shares outstanding: 613500000
Book value: 110956000000
P/B ratio: 1.1593113035797973
Market cap (USD): 128632544999.99998
Debt to equity: 0.46796928512203034
COGS to revenue (%): 0
SG&A to revenue (%): 34.53923829212054
Free cash flow (dilution-adjusted): 5442000000
Buyback yield (%): 0.5185312939272095
Retained earnings: 60892000000
Receivables turnover: 3.7287281351912243
Capitalized R&D asset: 0
FCF margin (%): 43.26946012562614
Revenue growth (%): 25.77
Rule of 40 score: 69.03946012562614
Financial ratios for COF — quarterly report dated 2025-09-30
Total revenue: 15464000000
Net income: 3192000000
Capital expenditures: 387000000
Operating cash flow: 9154000000
Depreciation & amortization: 1832000000
Net tangible assets: 67908000000
Owner earnings: 4637000000
Return on net tangible assets (%): 6.828356011073805
Buffett classification: The Gruesome
Stock price: 210.07
P/E ratio: 404.00609717868343
Shares outstanding: 613500000
Book value: 113813000000
P/B ratio: 1.1323657666523157
Market cap (USD): 128877945000
Debt to equity: 0.4469260980731551
Effective tax rate (%): 27.133728890917393
COGS to revenue (%): 0
SG&A to revenue (%): 31.680031039834454
Free cash flow (dilution-adjusted): 8593000000
Buyback yield (%): 0.8046372868530764
Retained earnings: 63624000000
Receivables turnover: 4.474537037037037
Capitalized R&D asset: 0
FCF margin (%): 55.56777030522504
Revenue growth (%): 22.95459966605709
Rule of 40 score: 78.52236997128213
Financial ratios for COF — annual report dated 2025-12-31
Total revenue: 53434000000
Net income: 2453000000
Capital expenditures: 1578000000
Operating cash flow: 27718000000
Depreciation & amortization: 5260000000
Net tangible assets: 68529000000
Owner earnings: 6135000000
Return on net tangible assets (%): 8.952414306352056
Buffett classification: The Gruesome
Stock price: 240.4
P/E ratio: 60.124500611496124
Shares outstanding: 613500000
Book value: 113616000000
P/B ratio: 1.298104140261935
Market cap (USD): 147485400000
Debt to equity: 0.4437139135333052
Effective tax rate (%): 8.461201227531784
COGS to revenue (%): 0
SG&A to revenue (%): 34.350787887861664
Free cash flow (dilution-adjusted): 25364000000
Buyback yield (%): 3.1182747580438472
Retained earnings: 65192000000
Receivables turnover: 15.301832760595648
Capitalized R&D asset: 0
FCF margin (%): 47.46790433057604
Revenue growth (%): 36.61791777459603
Rule of 40 score: 84.08582210517207
Financial ratios for COF — quarterly report dated 2025-12-31
Total revenue: 15393000000
Net income: 2134000000
Capital expenditures: 444000000
Operating cash flow: 7831000000
Depreciation & amortization: 1605000000
Net tangible assets: 68529000000
Owner earnings: 3295000000
Return on net tangible assets (%): 4.80818339681011
Buffett classification: The Gruesome
Stock price: 240.4
P/E ratio: 60.124500611496124
Shares outstanding: 613500000
Book value: 113616000000
P/B ratio: 1.298104140261935
Market cap (USD): 147485400000
Debt to equity: 0.4437139135333052
Effective tax rate (%): 16.43639828489757
COGS to revenue (%): 0
SG&A to revenue (%): 34.84700838043266
Free cash flow (dilution-adjusted): 7187000000
Buyback yield (%): 1.7086437030377246
Retained earnings: 65192000000
Receivables turnover: 4.408075601374571
Capitalized R&D asset: 0
FCF margin (%): 46.690053920613266
Revenue growth (%): -0.4591308846352819
Rule of 40 score: 46.23092303597799
Financial ratios for CPV.AX — annual report dated 2021-06-30
Gross profit: -73042.1052631579
Operating income: -6036482.706766917
Net income: -5200797.744360902
Capital expenditures: 232878.1954887218
Depreciation & amortization: 129905.26315789473
Net tangible assets: 12491654.887218045
Owner earnings: -5303770.67669173
Return on net tangible assets (%): -42.458511098627596
Buffett classification: The Gruesome
Stock price: 0.3308270676691729
Shares outstanding: 364005606
Book value: 14665660.902255638
P/B ratio: 8.21121584978136
Market cap (USD): 120422907.2481203
Debt to equity: 0.012228247982897391
Current ratio: 22.61214935354259
Quick ratio: 22.61214935354259
Interest coverage ratio: -358.6883795737837
Free cash flow (dilution-adjusted): -2882587.2180451127
Buyback yield (%): 0.1258971619444584
Retained earnings: -12852491.729323307
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.74351780959064
Rule of 40 score: 0
Financial ratios for CPV.AX — annual report dated 2022-06-30
Total revenue: 198353.7931034483
Gross profit: -209682.75862068965
Operating income: -3388347.5862068967
Net income: -2893262.7586206896
Capital expenditures: 21199.310344827587
Depreciation & amortization: 143263.4482758621
Net tangible assets: 7078352.413793104
Owner earnings: -2771198.6206896547
Return on net tangible assets (%): -39.150334127043585
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 364005606
Book value: 12723650.344827587
P/B ratio: 3.946011437945075
Market cap (USD): 50207669.79310345
Debt to equity: 0.0094230169145235
Current ratio: 13.530689761205549
Quick ratio: 13.530689761205549
Interest coverage ratio: -332.28080616799673
COGS to revenue (%): 205.71149426486284
SG&A to revenue (%): 641.2244926341995
Free cash flow (dilution-adjusted): -3129182.7586206896
Buyback yield (%): 0
Retained earnings: -14516626.896551725
Receivables turnover: 0.3053628249243794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.431704031435473
FCF margin (%): -1577.5764655978692
Rule of 40 score: -1577.5764655978692
Financial ratios for CPV.AX — annual report dated 2023-06-30
Total revenue: 41927.15231788079
Gross profit: -367907.94701986754
Operating income: -5705660.927152318
Net income: -4962312.582781457
Capital expenditures: 251373.50993377483
Depreciation & amortization: 227795.3642384106
Net tangible assets: 1864468.8741721853
Owner earnings: -4985890.728476822
Return on net tangible assets (%): -267.4161418055602
Buffett classification: The Gruesome
Stock price: 0.11258278145695365
Shares outstanding: 364005606
Book value: 8916009.933774834
P/B ratio: 4.596312015553538
Market cap (USD): 40980763.58940397
Debt to equity: 0.011697166530183259
Current ratio: 4.924168853456079
Quick ratio: 4.905702737508173
Interest coverage ratio: -674.3013226892072
COGS to revenue (%): 977.493287000474
SG&A to revenue (%): 5871.7753909335015
Free cash flow (dilution-adjusted): -4463315.231788079
Buyback yield (%): 0
Retained earnings: -18326570.1986755
Inventory turnover: 23.923418895933203
Receivables turnover: 0.06275555467445122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -63.63320181830926
FCF margin (%): -10645.40514926552
Revenue growth (%): -78.86243985462161
Rule of 40 score: -10724.267589120142
Financial ratios for CQT.AX — annual report dated 2021-06-30
Total revenue: 2029882.7067669171
Gross profit: 1349219.5488721803
Operating income: -5978468.421052631
Net income: -4169621.804511278
Capital expenditures: 53521.80451127819
Depreciation & amortization: 137164.66165413533
Net tangible assets: 5698324.812030075
Owner earnings: -4085978.947368421
Return on net tangible assets (%): -71.70491472761023
Buffett classification: The Gruesome
Stock price: 0.48120300751879697
Shares outstanding: 905427480
Book value: 5947630.827067669
P/B ratio: 73.25512277650456
Market cap (USD): 435694426.46616536
Debt to equity: 0.18252544862432743
Current ratio: 2.8645104752349613
Quick ratio: 2.7276284842084957
Interest coverage ratio: -29.62681456420651
COGS to revenue (%): 33.53214230682613
R&D to revenue (%): 34.0073725508789
SG&A to revenue (%): 318.6736594284495
Free cash flow (dilution-adjusted): -3268777.4436090225
Buyback yield (%): 0.057535840694828484
Retained earnings: -40949134.58646616
Inventory turnover: 2.0378861210284858
Receivables turnover: 4.469693432735497
Capitalized R&D asset: 690309.7744360901
ROCI (R&D-adjusted, %): -82.12277217116777
FCF margin (%): -161.0328238529283
Rule of 40 score: -161.0328238529283
Financial ratios for CQT.AX — annual report dated 2022-06-30
Total revenue: 2804815.1724137934
Gross profit: 2110537.2413793104
Operating income: -8914077.931034483
Net income: -8144575.172413793
Capital expenditures: 290335.1724137931
Depreciation & amortization: 150895.86206896554
Net tangible assets: 4338226.206896552
Owner earnings: -8284014.482758622
Return on net tangible assets (%): -190.95395416655273
Buffett classification: The Gruesome
Stock price: 0.1931034482758621
Shares outstanding: 905427480
Book value: 4559526.206896552
P/B ratio: 38.34634578638162
Market cap (USD): 174841168.55172417
Debt to equity: 0.3231197796867279
Current ratio: 0.9441095777943501
Quick ratio: 0.7496519982367781
Interest coverage ratio: -56.70408651209721
COGS to revenue (%): 24.753072425695514
R&D to revenue (%): 58.43947674221326
SG&A to revenue (%): 329.231774323073
Free cash flow (dilution-adjusted): -6612943.448275862
Buyback yield (%): 0.05869918719813666
Retained earnings: -44735570.344827585
Inventory turnover: 1.0119916684593686
Receivables turnover: 4.724994132941732
Capitalized R&D asset: 2101626.859217008
ROCI (R&D-adjusted, %): -113.24003234284096
Rosenberg metric: 1.1028638456250253
FCF margin (%): -235.77109512655818
Revenue growth (%): 38.176218904842294
Rule of 40 score: -197.59487622171588
Financial ratios for CQT.AX — annual report dated 2023-06-30
Total revenue: 3049194.701986755
Gross profit: 2449294.701986755
Operating income: -13206312.582781456
Net income: -12507904.635761589
Capital expenditures: 38213.90728476821
Depreciation & amortization: 139791.3907284768
Net tangible assets: -914869.536423841
Owner earnings: -12406327.15231788
Buffett classification: The Gruesome
Stock price: 0.09271523178807947
Shares outstanding: 905427480
Book value: -495632.4503311254
Market cap (USD): 83946918.6754967
Debt to equity: -5.730587048456389
Current ratio: 0.8004358657568613
Quick ratio: 0.6881140239418647
Interest coverage ratio: -48.82018464069489
COGS to revenue (%): 19.67404703967001
R&D to revenue (%): 84.88338251941019
SG&A to revenue (%): 352.68719305759595
Free cash flow (dilution-adjusted): -7997765.562913908
Buyback yield (%): 0.42277583307153116
Retained earnings: -55465902.64900662
Inventory turnover: 0.5450696072437746
Receivables turnover: 2.0225506638775577
Capitalized R&D asset: 3914271.7661439506
ROCI (R&D-adjusted, %): -327.5028968544909
Rosenberg metric: 0.20667041042679116
FCF margin (%): -262.2910750075365
Revenue growth (%): 8.712856803418209
Rule of 40 score: -253.5782182041183
Financial ratios for CQT.AX — annual report dated 2024-06-30
Total revenue: 7270424
Gross profit: 6738508.666666667
Operating income: -4804656.666666667
Net income: -4510243.333333333
Capital expenditures: 78942
Depreciation & amortization: 151543.33333333334
Net tangible assets: 2311853.3333333335
Owner earnings: -4437642
Return on net tangible assets (%): -191.95170973937215
Buffett classification: The Gruesome
Stock price: 0.04666666666666667
Shares outstanding: 905427480
Book value: 2724987.333333333
P/B ratio: 15.50586378260841
Market cap (USD): 42253282.4
Debt to equity: 0.9450468393614552
Current ratio: 1.284843769712251
Quick ratio: 0.9687045438197422
Interest coverage ratio: -6.090777021488056
COGS to revenue (%): 7.316152858943761
R&D to revenue (%): 22.828462274002177
SG&A to revenue (%): 129.59507359314028
Free cash flow (dilution-adjusted): -5226675.333333333
Buyback yield (%): 1.0619119774388621
Retained earnings: -57793793.333333336
Inventory turnover: 0.31246213534896966
Receivables turnover: 29.186924592129493
Capitalized R&D asset: 3934769.3061886276
ROCI (R&D-adjusted, %): -73.1369358355937
Rosenberg metric: 1.657180740405649
FCF margin (%): -71.88955325484913
Revenue growth (%): 138.4375125426668
Rule of 40 score: 66.54795928781768
Financial ratios for CSGP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 79.03
Shares outstanding: 408355715
Market cap (USD): 32272352156.45
Buyback yield (%): 0.10322767872171293
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSGP — annual report dated 2022-12-31
Total revenue: 2182400000
Gross profit: 1768400000
Operating income: 451000000
Net income: 369500000
Capital expenditures: 63700000
Operating cash flow: 478700000
Depreciation & amortization: 137900000
Net tangible assets: 4225900000
Owner earnings: 443700000
Return on net tangible assets (%): 10.49953855983341
Capex to operating income (%): 14.124168514412416
Buffett classification: The Great
Stock price: 77.28
P/E ratio: 85.40657552151556
Shares outstanding: 408355715
Book value: 6870000000
P/B ratio: 4.593555990567686
Market cap (USD): 31557729655.2
Debt to equity: 0.1609315866084425
Current ratio: 13.914408371344244
Quick ratio: 13.914408371344244
Effective tax rate (%): 24.049331963001027
COGS to revenue (%): 18.969941348973606
R&D to revenue (%): 10.121884164222873
SG&A to revenue (%): 46.87041788856305
Free cash flow (dilution-adjusted): 309700000
Buyback yield (%): 0
Retained earnings: 1829600000
Receivables turnover: 14.180636777128004
Capitalized R&D asset: 220900000
ROCI (R&D-adjusted, %): 7.251101926705209
FCF margin (%): 14.190799120234605
Rule of 40 score: 14.190799120234605
Financial ratios for CSGP — annual report dated 2023-12-31
Total revenue: 2455000000
Gross profit: 1964000000
Operating income: 282000000
Net income: 375000000
Capital expenditures: 143000000
Operating cash flow: 490000000
Depreciation & amortization: 108000000
Net tangible assets: 4638700000
Owner earnings: 340000000
Return on net tangible assets (%): 7.32963976976308
Capex to operating income (%): 50.70921985815603
Buffett classification: The Good
Stock price: 87.39
P/E ratio: 95.1632158236
Shares outstanding: 408355715
Book value: 7338600000
P/B ratio: 4.862808428562668
Market cap (USD): 35686205933.85
Debt to equity: 0.15130951407625431
Current ratio: 12.014260640631855
Quick ratio: 12.014260640631855
Effective tax rate (%): 25.298804780876495
COGS to revenue (%): 20
R&D to revenue (%): 10.916496945010183
SG&A to revenue (%): 55.88594704684318
Free cash flow (dilution-adjusted): 262000000
Buyback yield (%): 0
Retained earnings: 2204300000
Receivables turnover: 12.921052631578947
Capitalized R&D asset: 416003000
ROCI (R&D-adjusted, %): 4.358531093564124
Rosenberg metric: 0.8854685377999094
FCF margin (%): 10.672097759674134
Revenue growth (%): 12.4908357771261
Rule of 40 score: 23.16293353680023
Financial ratios for CSGP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.44
Shares outstanding: 408355715
Market cap (USD): 30806355139.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSGP — annual report dated 2024-12-31
Total revenue: 2736000000
Gross profit: 2178000000
Operating income: 5000000
Net income: 139000000
Capital expenditures: 638000000
Operating cash flow: 393000000
Depreciation & amortization: 147000000
Net tangible assets: 4592000000
Owner earnings: -352000000
Return on net tangible assets (%): -7.665505226480835
Capex to operating income (%): 12760
Buffett classification: The Gruesome
Stock price: 71.59
P/E ratio: 210.31788227949642
Shares outstanding: 408355715
Book value: 7553000000
P/B ratio: 3.8705396050377336
Market cap (USD): 29234185636.850002
Debt to equity: 0.152389778895803
Current ratio: 8.967391304347826
Quick ratio: 8.967391304347826
Effective tax rate (%): 33.80952380952381
COGS to revenue (%): 20.394736842105264
R&D to revenue (%): 11.915204678362572
SG&A to revenue (%): 65.89912280701753
Free cash flow (dilution-adjusted): -334000000
Buyback yield (%): 0
Retained earnings: 2343000000
Receivables turnover: 14.553191489361701
Capitalized R&D asset: 578457000
ROCI (R&D-adjusted, %): 0.6394887881385856
Rosenberg metric: 0.7985074626865671
FCF margin (%): -12.207602339181287
Revenue growth (%): 11.44602851323829
Rule of 40 score: -0.7615738259429978
Financial ratios for CSGP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 71.59
Shares outstanding: 408355715
Market cap (USD): 29234185636.850002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSGP — quarterly report dated 2025-03-31
Total revenue: 732000000
Gross profit: 579000000
Operating income: -43000000
Net income: -15000000
Capital expenditures: 80000000
Operating cash flow: 53000000
Depreciation & amortization: 47000000
Net tangible assets: 3925800000
Owner earnings: -48000000
Return on net tangible assets (%): -1.2226807274950329
Buffett classification: The Gruesome
Stock price: 79.23
Shares outstanding: 408355715
Book value: 8556200000
P/B ratio: 3.781354257666955
Market cap (USD): 32354023299.45
Debt to equity: 0.13343540356700404
Current ratio: 6.009525124240751
Quick ratio: 6.009525124240751
COGS to revenue (%): 20.901639344262296
R&D to revenue (%): 12.978142076502733
SG&A to revenue (%): 69.67213114754098
Free cash flow (dilution-adjusted): -57000000
Buyback yield (%): 0.058725308516183794
Retained earnings: 2328200000
Receivables turnover: 3.536231884057971
Capitalized R&D asset: 95000000
ROCI (R&D-adjusted, %): 0.20751052010300683
FCF margin (%): -7.786885245901639
Rule of 40 score: -7.786885245901639
Financial ratios for CSGP — quarterly report dated 2025-06-30
Total revenue: 781300000
Gross profit: 613500000
Operating income: -27200000
Net income: 6200000
Capital expenditures: 149900000
Operating cash flow: 146700000
Depreciation & amortization: 65800000
Net tangible assets: 3996200000
Owner earnings: -77900000
Return on net tangible assets (%): -1.9493518842900754
Buffett classification: The Gruesome
Stock price: 80.4
P/E ratio: 1323.8628825
Shares outstanding: 408355715
Book value: 8601400000
P/B ratio: 3.8170297260911017
Market cap (USD): 32831799486.000004
Debt to equity: 0.13422233589880717
Current ratio: 5.834455818965517
Quick ratio: 5.834455818965517
Effective tax rate (%): 71.29629629629629
COGS to revenue (%): 21.477025470369895
R&D to revenue (%): 12.428004607705107
SG&A to revenue (%): 66.18456418789197
Free cash flow (dilution-adjusted): -56200000
Buyback yield (%): 0.1364530750716342
Retained earnings: 2334400000
Receivables turnover: 3.8336604514229635
Capitalized R&D asset: 160750000
ROCI (R&D-adjusted, %): 0.059107311675205304
Rosenberg metric: 0.3631578947368421
FCF margin (%): -7.1931396390631
Revenue growth (%): 6.7349726775956285
Rule of 40 score: -0.45816696146747127
Financial ratios for CSGP — quarterly report dated 2025-09-30
Total revenue: 833600000
Gross profit: 661400000
Operating income: -51100000
Net income: -30900000
Capital expenditures: 91300000
Operating cash flow: 68200000
Depreciation & amortization: 69200000
Net tangible assets: 1856000000
Owner earnings: -53000000
Return on net tangible assets (%): -2.855603448275862
Buffett classification: The Gruesome
Stock price: 84.37
Shares outstanding: 408355715
Book value: 8623900000
P/B ratio: 3.995056955037744
Market cap (USD): 34452971674.55
Debt to equity: 0.13659713122833056
Current ratio: 3.121479558728099
Quick ratio: 3.121479558728099
COGS to revenue (%): 20.657389635316697
R&D to revenue (%): 12.643953934740884
SG&A to revenue (%): 69.01391554702495
Free cash flow (dilution-adjusted): -94400000
Buyback yield (%): 0.14860837109682712
Retained earnings: 2303500000
Receivables turnover: 3.4191960623461854
Capitalized R&D asset: 201807000
ROCI (R&D-adjusted, %): -0.43767203868448534
Rosenberg metric: 0.4933058702368692
FCF margin (%): -11.324376199616124
Revenue growth (%): 6.693971585818508
Rule of 40 score: -4.630404613797616